YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells

Author:

Noguera Nelida Ines12ORCID,Travaglini Serena12ORCID,Scalea Stefania3,Catalanotto Caterina4,Reale Anna4,Zampieri Michele4,Zaza Alessandra25,Ricciardi Maria Rosaria6ORCID,Angelini Daniela Francesca7ORCID,Tafuri Agostino6,Ottone Tiziana12,Voso Maria Teresa12ORCID,Zardo Giuseppe3

Affiliation:

1. Department of Biomedicine and Prevention, Tor Vergata University, 00133 Rome, Italy

2. Unit of Neuro-Oncoematologia, Santa Lucia Foundation IRCCS, 00143 Rome, Italy

3. Department of Experimental Medicine, Sapienza University, 00185 Rome, Italy

4. Department of Molecular Medicine, Sapienza University, 00185 Rome, Italy

5. Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University, 00185 Rome, Italy

6. Department of Clinical and Molecular Medicine, Sapienza University, 00185 Rome, Italy

7. Laboratory of Neuro-Immunology and Cytofluorimetry, Santa Lucia Foundation IRCCS, 00143 Rome, Italy

Abstract

In this study we analyzed the expression of Yin and Yang 1 protein (YY1), a member of the noncanonical PcG complexes, in AML patient samples and AML cell lines and the effect of YY1 downregulation on the AML differentiation block. Our results show that YY1 is significantly overexpressed in AML patient samples and AML cell lines and that YY1 knockdown relieves the differentiation block. YY1 downregulation in two AML cell lines (HL-60 and OCI-AML3) and one AML patient sample restored the expression of members of the CEBP protein family, increased the expression of extrinsic growth factors/receptors and surface antigenic markers, induced morphological cell characteristics typical of myeloid differentiation, and sensitized cells to retinoic acid treatment and to apoptosis. Overall, our data show that YY1 is not a secondary regulator of myeloid differentiation but that, if overexpressed, it can play a predominant role in myeloid differentiation block.

Funder

University of Rome Sapienza

Fondazione AIRC per la ricerca sul cancro ETS

Publisher

MDPI AG

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3